ANTIBODIES TO TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN SERUM OF PATIENTS TREATED WITH THE RECOMBINANT PROTEIN FOR ACUTE MYOCARDIAL-INFARCTION

被引:0
|
作者
CUGNO, M
BISIANI, G
CICARDI, M
MERLINI, PA
SPINOLA, A
AGOSTONI, A
机构
[1] UNIV MILAN,INST INTERNAL MED,I-20122 MILAN,ITALY
[2] NIGUARDA HOSP,DIV CARDIOL 2,MILAN,ITALY
来源
CLINICAL RESEARCH | 1994年 / 42卷 / 02期
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:A193 / A193
页数:1
相关论文
共 50 条
  • [21] COMPARATIVE PROPERTIES OF 2 CLINICAL PREPARATIONS OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    GARABEDIAN, HD
    GOLD, HK
    LEINBACH, RC
    JOHNS, JA
    YASUDA, T
    KANKE, M
    COLLEN, D
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (03) : 599 - 607
  • [22] PHARMACODYNAMICS OF THROMBOLYSIS WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR - CORRELATION WITH CHARACTERISTICS OF AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    STUMP, DC
    CALIFF, RM
    TOPOL, EJ
    SIGMON, K
    THORNTON, D
    MASEK, R
    ANDERSON, L
    COLLEN, D
    [J]. CIRCULATION, 1989, 80 (05) : 1222 - 1230
  • [23] PHARMACOKINETICS AND HEMOSTATIC STATUS DURING CONSECUTIVE INFUSIONS OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    SEIFRIED, E
    TANSWELL, P
    ELLBRUCK, D
    HAERER, W
    SCHMIDT, A
    [J]. THROMBOSIS AND HAEMOSTASIS, 1989, 61 (03) : 497 - 501
  • [24] ARRHYTHMIAS AFTER RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    MCNEILL, AJ
    CUNNINGHAM, SR
    SHANNON, JS
    CAMPBELL, NPS
    KHAN, MM
    PATTERSON, GC
    WEBB, SW
    ADGEY, AAJ
    [J]. BRITISH HEART JOURNAL, 1988, 59 (01): : 136 - 137
  • [25] EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX ON MORTALITY IN ACUTE MYOCARDIAL-INFARCTION
    HELD, PH
    TEO, KK
    YUSUF, S
    [J]. CIRCULATION, 1990, 82 (05) : 1668 - 1674
  • [26] EFFECTIVENESS OF MULTIPLE BOLUS ADMINISTRATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    KHAN, MI
    HACKETT, DR
    ANDREOTTI, F
    DAVIES, GJ
    REGAN, T
    HAIDER, AW
    MCFADDEN, E
    HALSON, P
    MASERI, A
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (16): : 1051 - 1056
  • [27] RANDOMIZED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION
    VERSTRAETE, M
    BORY, M
    COLLEN, D
    ERBEL, R
    LENNANE, RJ
    MATHEY, D
    MICHELS, HR
    SCHARTL, M
    UEBIS, R
    BERNARD, R
    BROWER, RW
    DEBONO, DP
    HUHMANN, W
    LUBSEN, J
    MEYER, J
    RUTSCH, W
    SCHMIDT, W
    VONESSEN, R
    [J]. LANCET, 1985, 1 (8433): : 842 - 847
  • [28] ACUTE PHASE REACTION, INFARCT SIZE AND IN-HOSPITAL MORBIDITY IN MYOCARDIAL-INFARCTION PATIENTS TREATED WITH STREPTOKINASE OR RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    PIETILA, K
    HARMOINEN, A
    TEPPO, AM
    [J]. ANNALS OF MEDICINE, 1991, 23 (05) : 529 - 535
  • [30] MONITORING OF FIBRIN GENERATION DURING THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL-INFARCTION WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    RAPOLD, HJ
    KUEMMERLI, H
    WEISS, M
    BAUR, H
    HAEBERLI, A
    [J]. CIRCULATION, 1989, 79 (05) : 980 - 989